Chinese (Simplified) 
Chinese (Traditional) 
English 
French 
Alemão 
Italian 
Japanese 
Norwegian 
Spanish 
5 min read
0 comments
Swiss multinational creates jobs in the US with billion-dollar investment from Roche; there are 12 vacancies in the areas of health, technology and operations — see how to work in the United States with a visa.
Swiss multinational Roche has announced a new investment plan in the United States that foresees the creation of more than 12 jobs in various sectors over the next five years. With an investment of US$50 billion, the company will expand its activities in the areas of research, development, manufacturing and distribution of medicines and diagnostics, consolidating its presence in several US states. The announcement, made through an official statement from the company, reinforces Roche's expansion strategy in the largest healthcare market in the world. Swiss multinational creates jobs in the US and promises to expand its employee base, which already exceeds 25 thousand employees, with emphasis on opportunities in Indiana, Pennsylvania, California, Massachusetts, New Jersey, Kentucky and Oregon.
Roche invests US$50 billion and expands units in the USA
Roche’s billion-dollar investment in the US will be distributed between the construction of new manufacturing facilities and research centers, as well as the modernization of existing infrastructure. In total, 13 new industrial and technological projects are planned, including the installation of:
- Um R&D center in Massachusetts focused on research into artificial intelligence, cardiovascular and metabolic diseases;
- One of the new gene therapy manufacturing plant state-of-the-art in Pennsylvania;
- One of the factory dedicated to continuous glucose monitoring in Indiana;
- Um production center with more than 84 thousand m² for innovative anti-obesity drugs;
- Significant expansions at existing Roche facilities in Arizona, Indiana, New Jersey and California.
The multinational reported that these measures aim to strengthen its capacity to meet the demand for rapid diagnostics, advanced therapies and personalized medicines in the United States.
-
With salaries of up to R$10,2 thousand, the city hall of the state of São Paulo opens more than 270 vacancies in a selection process for different areas!
-
Piracicaba City Hall opens 120 vacancies in a selection process for teachers with salaries of R$26,62 per hour/class
-
Public competition held by the City of Campinas offers 40 vacancies with salaries of up to R$7,4 thousand and opportunities for all levels
-
Job Summary 15/05/2025 – Offshore and down to earth — resume by email to several companies
Buy
More than 12 thousand jobs will be created directly and indirectly
According to the Roche statement, the more than 12 thousand new jobs will be distributed as follows:
- 1.000 direct vacancies in the company's new factories, laboratories and logistics units;
- 6.500 jobs in the construction sector, to make ongoing works viable;
- 4.500 indirect positions in areas such as technical support, supply chain, transportation and services.
The company also reported that there will be opportunities at different qualification levels, from production line workers to PhD researchers, data analysts, engineers and information technology professionals.
Swiss multinational creates jobs in the US with focus on healthcare innovation
With global headquarters in Basel, Roche is one of the largest pharmaceutical and diagnostics companies in the world, with a presence in more than 100 countries. In the United States, the group already has 24 operational units in eight states, in addition to distribution and innovation centers focused on genetic research and oncology.
The new investment cycle is part of the company's strategy of increase the delivery capacity of innovative medicines, especially in fast-growing areas such as oncology, metabolic diseases, digital health and artificial intelligence applied to medicine.
With the announcement, Roche joins the list of multinationals that reinforce investments in the USA as a way to strengthen local production, reduce dependence on global chains and accelerate the population's access to modern treatments.
How to apply for jobs at Roche USA
Brazilian professionals who dream of working abroad can benefit from this expansion. Roche allows international applications and frequently hires qualified foreigners to join its global team. To compete for Roche jobs in the United States, is required:
- Access the Roche careers portal: careers.roche.com
- Select the country “United States”;
- Filter by areas of interest (research, production, IT, logistics, etc.);
- Read carefully the requirements for each vacancy, such as training, experience and fluency in the language;
- Send the resume in English and fill in the details on the online form.
It is important to be aware of work visa requirements. In many cases, Roche supports the H-1B visa process for qualified professionals. The company may also offer relocation packages, depending on the role and the urgency of the hiring.
US jobs: healthcare and technology lead demand for foreigners
Roche's decision to expand its operations in the United States comes at a time of labor shortage qualified professionals in the country, especially in the areas of science, engineering, health and technology. It is estimated that by 2030, the US healthcare sector will need to fill more than 2 million new positions to meet the growing demand for specialized services.
As a result, multinationals operating in the area of biotechnology and diagnostics — such as Roche — have expanded hiring and facilitated foreigners' access to opportunities in the US, whether through partnerships with universities, exchange programs or direct hiring of talent with international experience.
Investments strengthen Roche's presence as a global reference
With this new cycle of contributions, the Roche strengthens its position as a leader in pharmaceutical and diagnostic solutions, with a focus on innovation, technology and sustainable production. The expansion of facilities in the USA seeks reduce delivery times, improve logistics and make patient care more agile, especially in high-cost treatments.
The Swiss multinational also reaffirms its commitment to sustainability and social impact, ensuring that new centers are built with green technology, efficient energy use and zero emission targets by 2050.
